
Melissa Jean Perreira
Examiner (ID: 10386, Phone: (571)272-1354 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1065 |
| Issued Applications | 491 |
| Pending Applications | 87 |
| Abandoned Applications | 511 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9354734
[patent_doc_number] => 08673265
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-18
[patent_title] => 'Carbonylporphyrins and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/608305
[patent_app_country] => US
[patent_app_date] => 2012-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8614
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13608305
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/608305 | Carbonylporphyrins and uses thereof | Sep 9, 2012 | Issued |
Array
(
[id] => 11388771
[patent_doc_number] => 09550000
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-24
[patent_title] => 'Compositions, methods, and systems for the synthesis and use of imaging agents'
[patent_app_type] => utility
[patent_app_number] => 14/343627
[patent_app_country] => US
[patent_app_date] => 2012-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 27
[patent_no_of_words] => 91361
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343627
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/343627 | Compositions, methods, and systems for the synthesis and use of imaging agents | Sep 6, 2012 | Issued |
Array
(
[id] => 8814123
[patent_doc_number] => 20130115168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'Catalytic Radiofluorination'
[patent_app_type] => utility
[patent_app_number] => 13/602810
[patent_app_country] => US
[patent_app_date] => 2012-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 32320
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13602810
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/602810 | Catalytic radiofluorination | Sep 3, 2012 | Issued |
Array
(
[id] => 8587003
[patent_doc_number] => 20130005823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-03
[patent_title] => 'METHODS AND COMPOSITIONS FOR DETERRING ABUSE OF ORALLY ADMINISTERED PHARMACEUTICAL PRODUCTS'
[patent_app_type] => utility
[patent_app_number] => 13/601239
[patent_app_country] => US
[patent_app_date] => 2012-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 22977
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13601239
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/601239 | METHODS AND COMPOSITIONS FOR DETERRING ABUSE OF ORALLY ADMINISTERED PHARMACEUTICAL PRODUCTS | Aug 30, 2012 | Abandoned |
Array
(
[id] => 9338294
[patent_doc_number] => 20140065076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'CONTAINER WITH CONCENTRATED SUBSTANCE AND METHOD OF USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/599045
[patent_app_country] => US
[patent_app_date] => 2012-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6246
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13599045
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/599045 | CONTAINER WITH CONCENTRATED SUBSTANCE AND METHOD OF USING THE SAME | Aug 29, 2012 | Abandoned |
Array
(
[id] => 10844008
[patent_doc_number] => 08871179
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-28
[patent_title] => 'Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid'
[patent_app_type] => utility
[patent_app_number] => 13/595546
[patent_app_country] => US
[patent_app_date] => 2012-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 21759
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13595546
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/595546 | Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid | Aug 26, 2012 | Issued |
Array
(
[id] => 10830751
[patent_doc_number] => 08858913
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-14
[patent_title] => 'Multimeric peptidomimetic fibrosis specific dual-modality probes'
[patent_app_type] => utility
[patent_app_number] => 13/595515
[patent_app_country] => US
[patent_app_date] => 2012-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4754
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13595515
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/595515 | Multimeric peptidomimetic fibrosis specific dual-modality probes | Aug 26, 2012 | Issued |
Array
(
[id] => 10938788
[patent_doc_number] => 20140341807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-20
[patent_title] => 'PET TRACER FOR IMAGING OF NEUROENDOCRINE TUMORS'
[patent_app_type] => utility
[patent_app_number] => 14/241958
[patent_app_country] => US
[patent_app_date] => 2012-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5306
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14241958
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/241958 | Pet tracer for imaging of neuroendocrine tumors | Aug 22, 2012 | Issued |
Array
(
[id] => 9331288
[patent_doc_number] => 20140058071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'FIBROSIS SPECIFIC MULTIMERIC PEPTIDOMIMETIC RADIOTRACERS'
[patent_app_type] => utility
[patent_app_number] => 13/590189
[patent_app_country] => US
[patent_app_date] => 2012-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5038
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13590189
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/590189 | Fibrosis specific multimeric peptidomimetic radiotracers | Aug 20, 2012 | Issued |
Array
(
[id] => 8670622
[patent_doc_number] => 20130045160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-21
[patent_title] => 'Magnetic Nano-Composite for Contrast Agent, Intelligent Contrast Agent, Drug Delivery Agent for Simultaneous Diagnosis and Treatment, and Separation Agent for Target Substance'
[patent_app_type] => utility
[patent_app_number] => 13/590958
[patent_app_country] => US
[patent_app_date] => 2012-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 20783
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13590958
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/590958 | Magnetic Nano-Composite for Contrast Agent, Intelligent Contrast Agent, Drug Delivery Agent for Simultaneous Diagnosis and Treatment, and Separation Agent for Target Substance | Aug 20, 2012 | Abandoned |
Array
(
[id] => 8648766
[patent_doc_number] => 20130034496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-07
[patent_title] => 'POSITRON EMISSION TOMOGRAPHY TRACER'
[patent_app_type] => utility
[patent_app_number] => 13/565599
[patent_app_country] => US
[patent_app_date] => 2012-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10655
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13565599
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/565599 | POSITRON EMISSION TOMOGRAPHY TRACER | Aug 1, 2012 | Abandoned |
Array
(
[id] => 8496472
[patent_doc_number] => 20120295880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'Compounds With Modifying Activity Enhanced Under Hypoxic Conditions'
[patent_app_type] => utility
[patent_app_number] => 13/564169
[patent_app_country] => US
[patent_app_date] => 2012-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8839
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13564169
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/564169 | Compounds with modifying activity enhanced under hypoxic conditions | Jul 31, 2012 | Issued |
Array
(
[id] => 8939388
[patent_doc_number] => 20130189185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'Boron-Based Dual Imaging Probes, Compositions and Methods for Rapid Aqueous F-18 Labeling, and Imaging Methods Using Same'
[patent_app_type] => utility
[patent_app_number] => 13/549309
[patent_app_country] => US
[patent_app_date] => 2012-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9850
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13549309
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/549309 | Boron-based dual imaging probes, compositions and methods for rapid aqueous F-18 labeling, and imaging methods using same | Jul 12, 2012 | Issued |
Array
(
[id] => 8452697
[patent_doc_number] => 20120263643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-18
[patent_title] => 'BRACHYTHERAPY SEED'
[patent_app_type] => utility
[patent_app_number] => 13/538444
[patent_app_country] => US
[patent_app_date] => 2012-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9893
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13538444
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/538444 | BRACHYTHERAPY SEED | Jun 28, 2012 | Abandoned |
Array
(
[id] => 11388769
[patent_doc_number] => 09550001
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-24
[patent_title] => 'Compositions, methods of synthesis and use of carbohydrate targeted agents'
[patent_app_type] => utility
[patent_app_number] => 14/128347
[patent_app_country] => US
[patent_app_date] => 2012-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 47
[patent_no_of_words] => 9725
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14128347
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/128347 | Compositions, methods of synthesis and use of carbohydrate targeted agents | Jun 19, 2012 | Issued |
Array
(
[id] => 9602561
[patent_doc_number] => 20140199243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-17
[patent_title] => 'BIFUNCTIONAL PHOSPHONATE CHELATING AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/126486
[patent_app_country] => US
[patent_app_date] => 2012-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 19102
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14126486
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/126486 | BIFUNCTIONAL PHOSPHONATE CHELATING AGENTS | Jun 17, 2012 | Abandoned |
Array
(
[id] => 8429762
[patent_doc_number] => 20120251637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'Abuse-proofed dosage form'
[patent_app_type] => utility
[patent_app_number] => 13/517891
[patent_app_country] => US
[patent_app_date] => 2012-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10878
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13517891
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/517891 | Abuse-proofed dosage form | Jun 13, 2012 | Abandoned |
Array
(
[id] => 8453227
[patent_doc_number] => 20120264174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-18
[patent_title] => 'ASSAY FOR VITAMIN B12 ABSORPTION AND METHOD OF MAKING LABELED VITAMIN B12'
[patent_app_type] => utility
[patent_app_number] => 13/523662
[patent_app_country] => US
[patent_app_date] => 2012-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12759
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13523662
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/523662 | ASSAY FOR VITAMIN B12 ABSORPTION AND METHOD OF MAKING LABELED VITAMIN B12 | Jun 13, 2012 | Abandoned |
Array
(
[id] => 9435101
[patent_doc_number] => 20140113008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-24
[patent_title] => 'ASSESSMENT OF IRON DEPOSITION POST MYOCARDIAL INFARCTION AS A MARKER OF MYOCARDIAL HEMORRHAGE'
[patent_app_type] => utility
[patent_app_number] => 14/125307
[patent_app_country] => US
[patent_app_date] => 2012-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15269
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14125307
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/125307 | Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage | Jun 12, 2012 | Issued |
Array
(
[id] => 9517689
[patent_doc_number] => 20140154182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'N,N-SUBSTITUTED GUANIDINE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 14/122691
[patent_app_country] => US
[patent_app_date] => 2012-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9143
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14122691
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/122691 | N,N-SUBSTITUTED GUANIDINE COMPOUND | May 29, 2012 | Abandoned |